ArticleCurrent microbiology2025
Prevalence and Genotype Distribution of Human Papillomavirus in 23,495 Cases in Guangzhou City, Guangdong Province, China.
Article in Current microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Oncogenic viruses and their role in oral cavity and oropharyngeal squamous cell carcinoma: a systematic review.Frontiers in oncology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Human papillomavirus (HPV) is a widespread oncogenic virus that causes diseases from benign warts to life-threatening cervical, anogenital and oropharyngeal cancers. In Southern China, while the epidemiology of HPV in females is established, data on males remain limited to high-risk populations. Our study analyzed the characteristics of HPV infection across genders in Guangzhou, aiming to inform targeted screening strategies and vaccine promotion efforts. Among 23,495 participants attending the Affiliated Guangdong Second Provincial General Hospital of Jinan University from 2020 to 2024, the overall HPV prevalence was 21.98%, with male patients (33.70%) showing significantly higher rate than female patients (25.54%) and physical examinees (13.06%) (p < 0.001). Gender-specific genotype patterns emerged: male patients showed the highest prevalence of HPV6 (7.95%), HPV11 (3.81%), HPV16 (3.70%), HPV52 (3.64%) and HPV51 (3.57%); among female patients were HPV52 (5.23%), HPV58 (2.96%), HPV16 (2.68%), HPV39 (2.08%), and HPV51 (2.03%); physical examinees were HPV52 (2.66%), HPV58 (1.21%), HPV39 (1.10%), HPV51 (1.03%) and HPV54 (0.94%). Male patients exhibited higher prevalence of HPV6, HPV11, and oncogenic HPV18, while female patients showed HPV52 predominance. Age-related trends differed: male patients showed a linear increase (peaking at ≥ 55 years, p = 0.134), while female patients and physical examinees displayed U-shaped curves (peaking at < 25 and ≥ 55 years, both p < 0.001). The single-HPV genotype infection of the population predominated over the double and multiple infection. Clinically, female inpatients had higher rates of HPV16 (4.18% versus 2.63%, p = 0.05) and HPV56 (2.09% vs. 1.42%, p = 0.043) than outpatients. These findings have important implications for regional HPV prevention strategies in Southern China.
Indexed as
Identifiers
41021033What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.